Aptose Biosciences advances its Phase 1/2 TUSCANY trial, escalating tuspetinib dosing after a favorable safety review. Enrollment continues across U.S. sites.

Explore our curated list of the best penny stock trading apps and find the platform that best suits your budget and trading ...

Virpax completed a U.S. Army-backed Probudur study, showing potential for prolonged pain relief and reduced opioid use in surgical recovery.

Gen Z is changing the game when it comes to investing as the stock market is not just for experienced investors anymore.

Fortinet (NASDAQ: FTNT) stock has been in scintillating form on the stock market over the past six months, rising a ...

A report from the KZN Department of Health reveals that medication stock levels at healthcare facilities are at 80%, prompting discussions on management practices and supply chain efficiency ...

Learn how to identify penny stocks that could become big winners! Whether you're a trader looking for quick gains or a long-term investor seeking hidden gems, this guide walks you through how you can ...

However, it is still profitable and growth is pretty good here. Revenue increased 23% year-over-year to $15.26 million and ...

Global markets have been experiencing fluctuations, with U.S. stocks ending the week lower due to tariff uncertainties and mixed economic data, while European indices showed resilience despite trade ...

Recent legal issues have affected its stock price significantly, while Marqeta continues to explore strategic acquisitions to enhance program management capabilities without disrupting its ...